Live Stock Vaccine Market

Live Stock Vaccine Market Size and Share Forecast Outlook From 2024 to 2034

The livestock vaccine market is predicted to be valued at USD 6.1 billion in 2024 and rise to USD 11.2 billion by 2034. The market is expected to grow at a CAGR of 6.2% during the forecast period.

Key Market Drivers

With the objective of giving the animal a vaccine to stimulate the immune system to form antibodies for the upliftment of their well-being, there is a huge rise in the livestock vaccine market. Some factors are mentioned below-

• The increasing demand for protein-rich diets, especially meat and dairy products, is leading to the need for healthy livestock populations and a surge in the demand for vaccines to prevent diseases.
• Rise in the prevalence of diseases among livestock causes significant economic loss. Thus, vaccination is becoming a crucial preventive measure for controlling and managing diseases effectively.
• With increasing government initiatives to eradicate livestock diseases, aiming to enhance food security and public health, demand for vaccination increasing.
• Ongoing innovations in biotechnology and genetic engineering enhance the efficacy and convenience of vaccination, encouraging their adoption among livestock producers.
• Livestock vaccines play a crucial role in preventing zoonotic diseases at their source, as there is an emphasis on the prevention of zoonotic diseases that can be transmitted between animals and humans.
• Rapid expansion in the livestock industry in emerging markets is driven by urbanization, rising disposable incomes, and changing dietary preferences. This serves as an opportunity for vaccine manufacturers to meet the increasing demand for livestock vaccines.
• With the globalization of trade in livestock and livestock products, vaccination plays a crucial role in mitigating this risk by ensuring the health and biosecurity of livestock populations.

Attributes	Key Statistics
Live Stock Vaccine Market Value (2024)	USD 6.1 billion
Anticipated Market Value (2034)	USD 11.2 billion
Estimated Growth (2024 to 2034)	6.2 % CAGR

Lucrative Opportunities Driving Adoption of Live Stock Vaccines Across Diverse Applications

Despite the healthy growth of the livestock vaccine market in healthcare sectors, several factors are slowing down the market.

• Livestock producers are increasingly seeking to ensure consistent livestock health to ensure a reliable supply of high-quality products for consumers.
• In the livestock industry, there is a shift towards proactive and preventive healthcare practices, resulting in a preference for vaccination over curative treatments.
• Vaccines are viewed as cost-effective, reliable, and environment-friendly means of disease prevention, which urges widespread adoption.
• The surge in the sales of livestock vaccines to prevent outbreaks affecting livestock, producers prioritize disease control measures to protect their herds and mitigate losses.
• During trade restrictions or disease-related trade bans, there is a heightened demand for livestock vaccines to ensure compliance with biosecurity regulations and maintain access to export markets. This results in increased sales and adoption of vaccines.
• Continued investments in research and development drive innovation in the livestock vaccine market. New and improved vaccines enhance their popularity among livestock producers, compelling market growth and sales.

Factors Restraining the Demand for Live Stock Vaccines

• Strict regulatory requirements for vaccine approval and registration can delay market entry and increase development costs.
• Limited awareness among livestock producers about the importance and benefits of vaccination can inhibit market growth.
• Inadequate infrastructure and limited access to cold chain facilities in remote or rural areas can affect vaccine distribution and efficacy.
• High upfront costs associated with implementing vaccination programs, including vaccine procurement, storage, and administration, can dissuade adoption, especially among small-scale farmers.
• Perceived or actual issues related to vaccine efficacy, such as low effectiveness against certain strains of pathogens, can undermine confidence in vaccination programs.
• Inadequate biosecurity measures on farms, such as poor sanitation practices and lack of quarantine protocols increases the risk of disease transmission and reduce the effectiveness of vaccination efforts.
• Insufficient funding for research and development in veterinary vaccines may limit innovation and the development of new and improved vaccine formulations.

Live Stock Vaccine Industry Analysis by Top Investment Segments

Broader Spectrum Coverage of Inactivated Vaccine Aids in Market Development

Inactivate vaccines ensure quality assurance and validation, upsurging the global livestock vaccine market with a 6.0% CAGR through 2034.

Attributes	Details
Top Type	Inactivated
CAGR (2024 to 2034)	6.0%

• Efficacy, safety, and regulatory compliance make inactivated vaccines top choice in the livestock vaccine market. These vaccines contain killed pathogens or antigens, making them suitable for a wide range of livestock species without the risk of causing disease.
• Manufacturers prefer inactivated vaccines as they have a longer shelf life and do not require strict cold chain storage, facilitating distribution and administration in diverse geographical regions.
• Inactivated vaccines possess established safety profiles and compatibility with breeding animals and young livestock, further contributing to their popularity among producers and veterinarians.

Large Market Size and Global Importance of Bovine Vaccine

Bovine vaccines are crucial in economic and productivity concerns, heightening the global livestock vaccine market by 5.8% CAGR from 2024 to 2034.

Attributes	Details
Top Animal Type	Bovine
CAGR (2024 to 2034)	5.8%

• Enormous economic importance of cattle farming worldwide makes bovine vaccines a highly favorable choice in the livestock vaccine market.
• Cattle contribute to a significant portion of the global livestock population and are essential for meat, dairy, and leather production. Farmers and producers maintain the health and productivity of their cattle herds for better outcomes.
• Bovine vaccines are specifically designed to combat prevalent diseases such as bovine viral diarrhea (BVD), bovine respiratory syncytial virus (BRSV), and infectious bovine rhinotracheitis (IBR). These diseases significantly affect productivity and cause economic downtrend in industry.

Analysis of Top Countries Manufacturing, Certifying, Distributing, and Using Live Stock Vaccines

The section analyzes the global livestock vaccine market by country, including the United Kingdom, the United States, China, South Korea, and Japan.

The table presents the CAGR for each country, indicating the expected market growth through 2034.

Countries	CAGR (2024 to 2034)
South Korea	8.0%
Japan	7.9%
United Kingdom	7.4%
China	6.8%
United States	6.4%

Expansion of the South Korea's Livestock Vaccine Market Due to Increased Disease Prevention Awareness

With growing demand for personalized medicine and advancements in precision healthcare, South Korea is well-positioned to capitalize on the opportunities presented by the expanding global livestock vaccine market with a CAGR of 8.0% from 2024 to 2034.

South Korea is investing in research and development to create innovative vaccine solutions to cater to the needs of the livestock sector. The market presents opportunities for collaborations with global vaccine manufacturers to introduce advanced technologies, expansion of vaccine production capabilities to meet both domestic and international demand, and the adoption of digital solutions for efficient vaccine distribution and administration.

South Korea's innovation in the field includes the development of novel vaccine delivery systems such as edible vaccines that offer convenience and improved efficacy. Future plans involve partnerships between public and private sectors to establish advance vaccine manufacturing facilities and enhance biosecurity measures to prevent disease outbreaks.

Market Expansion in Japan Driven by Increased Livestock Production

Japan is flourishing in the livestock vaccine market due to the country's growing emphasis on food safety, animal health, and sustainable agriculture. The market has a CAGR of 7.9%, which is expected to continue through 2034.

Japan is investing heavily in research and development, with a particular focus on improving the efficacy and safety of livestock vaccines. Collaboration between government agencies, academic institutions, and pharmaceutical companies is also on the rise, as they work together to create innovative vaccine solutions customized to meet the unique needs of the local livestock industry.

Notable organizations driving this growth include the National Institute of Animal Health and the Japan Livestock Technology Association, both actively engaged in vaccine research and development.

Emphasis on Technological Advancements Propelling Market Growth in the United Kingdom

The livestock vaccine market in the United Kingdom is projected to expand at a CAGR of 7.4% through 2034.

The United Kingdom is expanding with increased awareness of animal health and welfare. Growing Concerns about zoonotic diseases and government initiatives to support sustainable agriculture are uplifting the market growth. The United Kingdom is approaching this expansion by investing in research and development, fostering collaborations between academia and industry, and implementing regulatory measures to ensure the safety and efficacy of veterinary vaccines.

Famous centers such as the Pirbright Institute and the Roslin Institute play a crucial role in vaccine research and development, contributing to the expansion of the market. Upcoming projects like the United Kingdom Vaccine Manufacturing and Innovation Centre (VMIC) aim to strengthen the country's vaccine manufacturing capabilities and support the production of vaccines for livestock diseases.

Rising Demand and Modernization Soar the Livestock Vaccine Market in China

China is emerging as a key player in the livestock vaccine market. The market is projected to rise at a CAGR of 6.8% from 2024 to 2034. China is in a steady race to improve its veterinary healthcare sector.

Chinese government has made considerable efforts and investments in veterinary vaccines, prioritizing the health of livestock and food safety. These initiatives include research and development aimed at innovating vaccine formulations to tackle local disease challenges and production systems.

China has been actively promoting the use of vaccination programs among livestock producers through subsidies and educational campaigns, resulting in increased adoption rates. The demand for animal protein is also on the rise, along with the growth of the livestock industry leading to an escalating need for effective disease prevention measures in China.

Increasing Demand for Protein-Rich Diets and Government Support Drives the United States Market

Ongoing advancement and research in the United States soar market growth, with an expected CAGR of 6.4% until 2034.

The livestock vaccine market in the United States is expanding due to several factors. Innovative developments in veterinary vaccines, such as the introduction of novel formulations and delivery methods, have spurred growth by enhancing vaccine efficacy and safety. Research projects focused on improving disease prevention and management have contributed to market expansion, with initiatives aimed at addressing emerging livestock diseases and increasing vaccine accessibility.

Notable companies driving this growth include Zoetis, Merck Animal Health, and Elanco, which have a strong presence in the United States to develop cutting-edge vaccine solutions tailored to the needs of American livestock producers.

Key Live Stock Vaccine Market Players and Concentration

Manufacturers and major companies are taking proactive measures to expand their market presence, as they are witnessing high demand in the livestock vaccine market. Companies such as Zoetis, Merck Animal Health, and Elanco are investing in research and development to create innovative vaccine formulations and delivery methods, which enhance the efficacy and safety of the vaccines.

With the growing global demand for protein-rich diets and increased awareness of animal health and welfare, there are significant opportunities for manufacturers to capitalize on the expanding livestock vaccine market. Some of the emerging trends in this market, such as personalized vaccination programs and the development of vaccines for emerging diseases, present promising avenues for growth and differentiation.

Recent Developments

• On December 28, 2023, Indian Immunologicals (IIL), a biotechnology firm under the National Dairy Development Board (NDDB), initiated construction of its new vaccine manufacturing plant in Genome Valley, Hyderabad. The company had invested approximately Rs 700 crore in the facility.
• On February 23, 2024, Bangladeshi Fisheries and Livestock Minister Abdur Rahman announced the government's intention to produce foot and mouth disease (FMD) vaccine locally in response to the rapid growth of the domestic FMD vaccine market.
• On January 9, 2024, Zhengye Biotechnology (ZYBT), a livestock vaccine manufacturer that sells vaccines in China and other countries, filed for a $20M US IPO.
• On July 28, 2023, the Yobe State Government procured 1.5 million doses of anthrax vaccine for livestock. The move aimed to mitigate the spread of anthrax disease among animals.

Leading Suppliers of Live Stock Vaccine Solutions

• Boehringer Ingelheim International GmbH
• Virbac
• Merck Animal Health
• Ceva, Elanco

Key Shifting Preferences Covered in Live Stock Vaccine Market Report

• Detailed Study in Advances in Irradiated Livestock Vaccine Research
• Analysis of the Animal Vaccine Industry
• Vaccinations for the Beef Cattle Herd Demand Analysis
• Market Analysis on Veterinary Immunization Products
• Insights into the Types of Vaccines for Animals
• Difference Between 7 in 1 Vaccine For Cattle and 3 in 1 Vaccine For Cattle

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
  • 4.1. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type
    • 4.1.1. Inactivated
    • 4.1.2. Live Attenuated
    • 4.1.3. Recombinant
    • 4.1.4. Others
  • 4.2. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Animal Type
    • 4.2.1. Bovine
    • 4.2.2. Swine/Porcine
    • 4.2.3. Poultry
    • 4.2.4. Others
  • 4.3. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration
    • 4.3.1. Oral
    • 4.3.2. Parenteral
    • 4.3.3. Others
  • 4.4. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
    • 4.4.1. Veterinary Hospitals
    • 4.4.2. Veterinary Clinics
    • 4.4.3. Others
  • 4.5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    • 4.5.1. North America
    • 4.5.2. Latin America
    • 4.5.3. Western Europe
    • 4.5.4. Eastern Europe
    • 4.5.5. South Asia and Pacific
    • 4.5.6. East Asia
    • 4.5.7. Middle East and Africa
  • 5. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 6. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 7. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 8. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 9. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 10. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 11. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 12. Key Countries Market Analysis
  • 13. Market Structure Analysis
  • 14. Competition Analysis
    • 14.1. Boehringer Ingelheim International GmbH
    • 14.2. Virbac
    • 14.3. Merck Animal Health (Merck & Co., Inc.)
    • 14.4. Zoetis Services LLC
    • 14.5. Ceva
    • 14.6. Elanco
    • 14.7. HIPRA
    • 14.8. Neogen Corporation
    • 14.9. Dechra Pharmaceuticals PLC
    • 14.10. Biogénesis Bagó
  • 15. Assumptions & Acronyms Used
  • 16. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Volume (Vials) Forecast by Region, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 4: Global Market Volume (Vials) Forecast by Type, 2019 to 2034

Table 5: Global Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 6: Global Market Volume (Vials) Forecast by Animal Type, 2019 to 2034

Table 7: Global Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 8: Global Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034

Table 9: Global Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 10: Global Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034

Table 11: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 12: North America Market Volume (Vials) Forecast by Country, 2019 to 2034

Table 13: North America Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 14: North America Market Volume (Vials) Forecast by Type, 2019 to 2034

Table 15: North America Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 16: North America Market Volume (Vials) Forecast by Animal Type, 2019 to 2034

Table 17: North America Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 18: North America Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034

Table 19: North America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 20: North America Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034

Table 21: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 22: Latin America Market Volume (Vials) Forecast by Country, 2019 to 2034

Table 23: Latin America Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 24: Latin America Market Volume (Vials) Forecast by Type, 2019 to 2034

Table 25: Latin America Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 26: Latin America Market Volume (Vials) Forecast by Animal Type, 2019 to 2034

Table 27: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 28: Latin America Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034

Table 29: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 30: Latin America Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034

Table 31: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 32: Western Europe Market Volume (Vials) Forecast by Country, 2019 to 2034

Table 33: Western Europe Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 34: Western Europe Market Volume (Vials) Forecast by Type, 2019 to 2034

Table 35: Western Europe Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 36: Western Europe Market Volume (Vials) Forecast by Animal Type, 2019 to 2034

Table 37: Western Europe Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 38: Western Europe Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034

Table 39: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 40: Western Europe Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034

Table 41: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 42: Eastern Europe Market Volume (Vials) Forecast by Country, 2019 to 2034

Table 43: Eastern Europe Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 44: Eastern Europe Market Volume (Vials) Forecast by Type, 2019 to 2034

Table 45: Eastern Europe Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 46: Eastern Europe Market Volume (Vials) Forecast by Animal Type, 2019 to 2034

Table 47: Eastern Europe Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 48: Eastern Europe Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034

Table 49: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 50: Eastern Europe Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034

Table 51: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 52: South Asia and Pacific Market Volume (Vials) Forecast by Country, 2019 to 2034

Table 53: South Asia and Pacific Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 54: South Asia and Pacific Market Volume (Vials) Forecast by Type, 2019 to 2034

Table 55: South Asia and Pacific Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 56: South Asia and Pacific Market Volume (Vials) Forecast by Animal Type, 2019 to 2034

Table 57: South Asia and Pacific Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 58: South Asia and Pacific Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034

Table 59: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 60: South Asia and Pacific Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034

Table 61: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 62: East Asia Market Volume (Vials) Forecast by Country, 2019 to 2034

Table 63: East Asia Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 64: East Asia Market Volume (Vials) Forecast by Type, 2019 to 2034

Table 65: East Asia Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 66: East Asia Market Volume (Vials) Forecast by Animal Type, 2019 to 2034

Table 67: East Asia Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 68: East Asia Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034

Table 69: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 70: East Asia Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034

Table 71: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 72: Middle East and Africa Market Volume (Vials) Forecast by Country, 2019 to 2034

Table 73: Middle East and Africa Market Value (US$ Million) Forecast by Type, 2019 to 2034

Table 74: Middle East and Africa Market Volume (Vials) Forecast by Type, 2019 to 2034

Table 75: Middle East and Africa Market Value (US$ Million) Forecast by Animal Type, 2019 to 2034

Table 76: Middle East and Africa Market Volume (Vials) Forecast by Animal Type, 2019 to 2034

Table 77: Middle East and Africa Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034

Table 78: Middle East and Africa Market Volume (Vials) Forecast by Route of Administration, 2019 to 2034

Table 79: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034

Table 80: Middle East and Africa Market Volume (Vials) Forecast by Distribution Channel, 2019 to 2034

List of Figures

Figure 1: Global Market Value (US$ Million) by Type, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 4: Global Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 5: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 6: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 7: Global Market Volume (Vials) Analysis by Region, 2019 to 2034

Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 10: Global Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 11: Global Market Volume (Vials) Analysis by Type, 2019 to 2034

Figure 12: Global Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 13: Global Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 14: Global Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 15: Global Market Volume (Vials) Analysis by Animal Type, 2019 to 2034

Figure 16: Global Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 17: Global Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 18: Global Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 19: Global Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034

Figure 20: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 21: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 22: Global Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 23: Global Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034

Figure 24: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 25: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 26: Global Market Attractiveness by Type, 2024 to 2034

Figure 27: Global Market Attractiveness by Animal Type, 2024 to 2034

Figure 28: Global Market Attractiveness by Route of Administration, 2024 to 2034

Figure 29: Global Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 30: Global Market Attractiveness by Region, 2024 to 2034

Figure 31: North America Market Value (US$ Million) by Type, 2024 to 2034

Figure 32: North America Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 33: North America Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 34: North America Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 35: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 36: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 37: North America Market Volume (Vials) Analysis by Country, 2019 to 2034

Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 40: North America Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 41: North America Market Volume (Vials) Analysis by Type, 2019 to 2034

Figure 42: North America Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 43: North America Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 44: North America Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 45: North America Market Volume (Vials) Analysis by Animal Type, 2019 to 2034

Figure 46: North America Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 47: North America Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 48: North America Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 49: North America Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034

Figure 50: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 51: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 52: North America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 53: North America Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034

Figure 54: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 55: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 56: North America Market Attractiveness by Type, 2024 to 2034

Figure 57: North America Market Attractiveness by Animal Type, 2024 to 2034

Figure 58: North America Market Attractiveness by Route of Administration, 2024 to 2034

Figure 59: North America Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 60: North America Market Attractiveness by Country, 2024 to 2034

Figure 61: Latin America Market Value (US$ Million) by Type, 2024 to 2034

Figure 62: Latin America Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 63: Latin America Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 64: Latin America Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 65: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 66: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 67: Latin America Market Volume (Vials) Analysis by Country, 2019 to 2034

Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 70: Latin America Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 71: Latin America Market Volume (Vials) Analysis by Type, 2019 to 2034

Figure 72: Latin America Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 73: Latin America Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 74: Latin America Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 75: Latin America Market Volume (Vials) Analysis by Animal Type, 2019 to 2034

Figure 76: Latin America Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 77: Latin America Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 78: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 79: Latin America Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034

Figure 80: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 82: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 83: Latin America Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034

Figure 84: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 85: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 86: Latin America Market Attractiveness by Type, 2024 to 2034

Figure 87: Latin America Market Attractiveness by Animal Type, 2024 to 2034

Figure 88: Latin America Market Attractiveness by Route of Administration, 2024 to 2034

Figure 89: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 90: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 91: Western Europe Market Value (US$ Million) by Type, 2024 to 2034

Figure 92: Western Europe Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 93: Western Europe Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 94: Western Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 95: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 96: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 97: Western Europe Market Volume (Vials) Analysis by Country, 2019 to 2034

Figure 98: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 99: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 100: Western Europe Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 101: Western Europe Market Volume (Vials) Analysis by Type, 2019 to 2034

Figure 102: Western Europe Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 103: Western Europe Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 104: Western Europe Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 105: Western Europe Market Volume (Vials) Analysis by Animal Type, 2019 to 2034

Figure 106: Western Europe Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 107: Western Europe Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 108: Western Europe Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 109: Western Europe Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034

Figure 110: Western Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 111: Western Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 112: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 113: Western Europe Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034

Figure 114: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 115: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 116: Western Europe Market Attractiveness by Type, 2024 to 2034

Figure 117: Western Europe Market Attractiveness by Animal Type, 2024 to 2034

Figure 118: Western Europe Market Attractiveness by Route of Administration, 2024 to 2034

Figure 119: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 120: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 121: Eastern Europe Market Value (US$ Million) by Type, 2024 to 2034

Figure 122: Eastern Europe Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 123: Eastern Europe Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 124: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 125: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 126: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 127: Eastern Europe Market Volume (Vials) Analysis by Country, 2019 to 2034

Figure 128: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 129: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 130: Eastern Europe Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 131: Eastern Europe Market Volume (Vials) Analysis by Type, 2019 to 2034

Figure 132: Eastern Europe Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 133: Eastern Europe Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 134: Eastern Europe Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 135: Eastern Europe Market Volume (Vials) Analysis by Animal Type, 2019 to 2034

Figure 136: Eastern Europe Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 137: Eastern Europe Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 138: Eastern Europe Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 139: Eastern Europe Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034

Figure 140: Eastern Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 141: Eastern Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 142: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 143: Eastern Europe Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034

Figure 144: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 145: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 146: Eastern Europe Market Attractiveness by Type, 2024 to 2034

Figure 147: Eastern Europe Market Attractiveness by Animal Type, 2024 to 2034

Figure 148: Eastern Europe Market Attractiveness by Route of Administration, 2024 to 2034

Figure 149: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 150: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 151: South Asia and Pacific Market Value (US$ Million) by Type, 2024 to 2034

Figure 152: South Asia and Pacific Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 153: South Asia and Pacific Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 154: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 155: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 156: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 157: South Asia and Pacific Market Volume (Vials) Analysis by Country, 2019 to 2034

Figure 158: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 159: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 160: South Asia and Pacific Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 161: South Asia and Pacific Market Volume (Vials) Analysis by Type, 2019 to 2034

Figure 162: South Asia and Pacific Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 163: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 164: South Asia and Pacific Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 165: South Asia and Pacific Market Volume (Vials) Analysis by Animal Type, 2019 to 2034

Figure 166: South Asia and Pacific Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 167: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 168: South Asia and Pacific Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 169: South Asia and Pacific Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034

Figure 170: South Asia and Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 171: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 172: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 173: South Asia and Pacific Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034

Figure 174: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 175: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 176: South Asia and Pacific Market Attractiveness by Type, 2024 to 2034

Figure 177: South Asia and Pacific Market Attractiveness by Animal Type, 2024 to 2034

Figure 178: South Asia and Pacific Market Attractiveness by Route of Administration, 2024 to 2034

Figure 179: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 180: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 181: East Asia Market Value (US$ Million) by Type, 2024 to 2034

Figure 182: East Asia Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 183: East Asia Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 184: East Asia Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 185: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 186: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 187: East Asia Market Volume (Vials) Analysis by Country, 2019 to 2034

Figure 188: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 189: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 190: East Asia Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 191: East Asia Market Volume (Vials) Analysis by Type, 2019 to 2034

Figure 192: East Asia Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 193: East Asia Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 194: East Asia Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 195: East Asia Market Volume (Vials) Analysis by Animal Type, 2019 to 2034

Figure 196: East Asia Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 197: East Asia Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 198: East Asia Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 199: East Asia Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034

Figure 200: East Asia Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 201: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 202: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 203: East Asia Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034

Figure 204: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 205: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 206: East Asia Market Attractiveness by Type, 2024 to 2034

Figure 207: East Asia Market Attractiveness by Animal Type, 2024 to 2034

Figure 208: East Asia Market Attractiveness by Route of Administration, 2024 to 2034

Figure 209: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 210: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 211: Middle East and Africa Market Value (US$ Million) by Type, 2024 to 2034

Figure 212: Middle East and Africa Market Value (US$ Million) by Animal Type, 2024 to 2034

Figure 213: Middle East and Africa Market Value (US$ Million) by Route of Administration, 2024 to 2034

Figure 214: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2024 to 2034

Figure 215: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 216: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 217: Middle East and Africa Market Volume (Vials) Analysis by Country, 2019 to 2034

Figure 218: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 219: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 220: Middle East and Africa Market Value (US$ Million) Analysis by Type, 2019 to 2034

Figure 221: Middle East and Africa Market Volume (Vials) Analysis by Type, 2019 to 2034

Figure 222: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2024 to 2034

Figure 223: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2024 to 2034

Figure 224: Middle East and Africa Market Value (US$ Million) Analysis by Animal Type, 2019 to 2034

Figure 225: Middle East and Africa Market Volume (Vials) Analysis by Animal Type, 2019 to 2034

Figure 226: Middle East and Africa Market Value Share (%) and BPS Analysis by Animal Type, 2024 to 2034

Figure 227: Middle East and Africa Market Y-o-Y Growth (%) Projections by Animal Type, 2024 to 2034

Figure 228: Middle East and Africa Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034

Figure 229: Middle East and Africa Market Volume (Vials) Analysis by Route of Administration, 2019 to 2034

Figure 230: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034

Figure 231: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034

Figure 232: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034

Figure 233: Middle East and Africa Market Volume (Vials) Analysis by Distribution Channel, 2019 to 2034

Figure 234: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 235: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 236: Middle East and Africa Market Attractiveness by Type, 2024 to 2034

Figure 237: Middle East and Africa Market Attractiveness by Animal Type, 2024 to 2034

Figure 238: Middle East and Africa Market Attractiveness by Route of Administration, 2024 to 2034

Figure 239: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 240: Middle East and Africa Market Attractiveness by Country, 2024 to 2034